Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Other 1Breast 1

Conditions

Breast Neoplasms 13Obesity 3Triple Negative Breast Neoplasms 2Weight Gain 1Stage IV Breast Cancer AJCC v6 and v7 1Prostatic Neoplasms 1Patient Compliance 1Overweight 1Ovarian Neoplasms 1Motor Activity 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fatigue 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

pembrolizumab 24Paclitaxel 11Carboplatin 11Trastuzumab 9Nivolumab 7Fulvestrant 6palbociclib 4olaparib 4Taxes 4Surveys and Questionnaires 4Methods 4Early Intervention, Educational 4Docetaxel 4Cyclophosphamide 4Biopsy 4Bevacizumab 4pertuzumab 3lenvatinib 3fludarabine 3atezolizumab 3abemaciclib 3Tamoxifen 3Specimen Handling 3Psychiatric Rehabilitation 3Metformin 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Interviews as Topic 3Gemcitabine 3Counseling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Diet Therapy × Breast × Clear all
NCT02983279 2025-04-29

Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer

Thomas Jefferson University

Phase NA Completed
49 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡